Device / Technology News

RSS

U.S. District Court rules in favor of Alnylam in patent infringement case against Tekmira

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. District Court of the District of Massachusetts has ruled in favor of Alnylam and has denied Tekmira Pharmaceuticals Corporation's motion to dismiss certain claims and motion to disqualify Alnylam's counsel in an infringement suit filed in January 2012.

26 Sep 2012

New technique can identify cell-secreted proteins

Researchers from North Carolina State University have developed a new technique to identify the proteins secreted by a cell. The new approach should help researchers collect precise data on cell biology, which is critical in fields ranging from zoology to cancer research.

26 Sep 2012

New computer program predicts most stable structures of nanometer-sized collagen

The human body is proficient at making collagen. And human laboratories are getting better at it all the time. In a development that could lead to better drug design and new treatments for disease, Rice University researchers have made a major step toward synthesizing custom collagen. Rice scientists who have learned how to make collagen - the fibrous protein that binds cells together into organs and tissues - are now digging into its molecular structure to see how it forms and interacts with biological systems.

26 Sep 2012

NeuroSigma to launch Monarch eTNS system at 10th European Congress on Epileptology

NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch eTNS system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012.

25 Sep 2012

Positive results from Antares Pharma’s VIBEX MTX clinical study on rheumatoid arthritis

Antares Pharma, Inc. today announced positive results from an Actual Human Use (AHU) study for VIBEX Methotrexate (MTX).

25 Sep 2012

Pervenio Lung RS from Life Technologies

Life Technologies Corporation today announced the launch of Pervenio Lung RS. First-of-its-kind, the molecular test has been documented to reliably identify early stage lung cancer patients who are at high risk for mortality following surgery. It also fulfills an unmet need for prognostic information to guide preventative treatment and improve disease management.

25 Sep 2012

LIFR protein suppresses local invasion and metastasis of breast cancer cells

A receptor protein suppresses local invasion and metastasis of breast cancer cells, the most lethal aspect of the disease, according to a research team headed by scientists from The University of Texas MD Anderson Cancer Center.

25 Sep 2012

NVIDIA video cards can help reduce radiation exposure from X-ray and CT scans

Video gamers are generally the biggest consumers of computer graphics cards, using the devices to boost the speed and resolution of their digital quests to fend off invading extraterrestrials or outwit hostile dragons. But researchers at Rensselaer Polytechnic Institute seek to harness the power of these computer graphics cards to solve one of the world's most pressing health care technology challenges: radiation exposure from X-ray and CT imaging scans.

25 Sep 2012

X2IMPACT, NFL enter agreement to supply Concussion Management System software app

X2IMPACT, a privately funded Seattle company, today announced that it has entered into an agreement with the National Football League to supply its Concussion Management System (CMS) software application for use by certain teams of the NFL during the 2012 football season.

25 Sep 2012

Lack of cytokeratin 6A may lead to eye infections

Exposed tissue surfaces, including skin and mucous membranes, are under constant threat of attack by microorganisms in the environment. The layer of cells that line these areas, known as epithelial cells, are the first line of defense against these pathogens, but the underlying molecular mechanisms that allow them to repel microbes are unknown.

25 Sep 2012

Toshiba announces expansion of Assurance Program to offer ultrasound systems

To provide increased value to healthcare facilities, Toshiba America Medical Systems, Inc. expands its Assurance Program to offer reconditioned Toshiba ultrasound systems. Assurance ultrasound products include Aplio XG, Aplio MX, Aplio Artida, Viamo, and Xario XG.

25 Sep 2012

Endorectal MRI helps assess eligibility of men with prostate cancer for active surveillance

PSA screening has resulted in improved prostate cancer survival, but the high rate of diagnosis and treatment side effects raise concerns about overtreatment. In the quest to prevent overtreatment, "active surveillance" has emerged as a plausible option, encouraged for men whose tumors may not need immediate treatment and may never progress to more serious illness. Appropriate criteria for selecting patients for active surveillance are continuously debated.

25 Sep 2012

Amcom Software launches clinical alerting middleware at St. Vincent's Melbourne

Amcom Software's Australian division today announced the launch of its Amcom Messenger clinical alerting middleware at St. Vincent's Melbourne, covering the Fitzroy, Caritas Christi, and St. George campuses.

25 Sep 2012

Celleration introduces new MIST 360 Applicator

Celleration, Inc., a privately held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announces the launch of its new MIST 360 Applicator.

25 Sep 2012

New nanotechnology detects micrometastases in mouse models of breast cancer

Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths. New nanotechnology developed at Case Western Reserve University detects these metastases in mouse models of breast cancer far earlier than current methods, a step toward earlier, life-saving diagnosis and treatment.

25 Sep 2012

PAM50 potentially simplifies underlying breast tumor biology

On September 23, researchers published online in the journal Nature a study of the molecular biology of breast cancer, using the intrinsic subtypes as defined by the PAM50 gene signature as an organizing framework for analyzing genomic and proteomic aberrations. This landmark study both underscores the emergence of the intrinsic subtypes as a powerful taxonomy of breast cancer in research, and PAM50's role as the gold standard for categorizing breast cancer by subtype.

From NanoString Technologies 25 Sep 2012

Combination of healing touch and guided imagery reduces depression, cynicism among US Marines

Healing touch combined with guided imagery (HT+GI) provides significant clinical reductions in post-traumatic stress disorder (PTSD) symptoms for combat-exposed active duty military, according to a study released in the September issue of Military Medicine.

25 Sep 2012

Study tracks and compares brain growth in chimpanzee and human fetuses

Humans' superior brain size in comparison to their chimpanzee cousins traces all the way back to the womb. That's according to a study reported in the September 25 issue of Current Biology, a Cell Press publication, that is the first to track and compare brain growth in chimpanzee and human fetuses.

25 Sep 2012

Siemens perioperative management solution by SIS for Wentworth-Douglass Hospital

Surgical Information Systems, a leader in perioperative information systems, announced today that Wentworth-Douglass Hospital has selected Siemens perioperative management solution by SIS to replace its legacy perioperative IT system and automate its anesthesia documentation.

From Siemens Healthineers 24 Sep 2012

Lasers manipulate neurons in worms' brains

In the quest to understand how the brain turns sensory input into behavior, Harvard scientists have crossed a major threshold. Using precisely-targeted lasers, researchers have been able to take over an animal's brain, instruct it to turn in any direction they choose, and even to implant false sensory information, fooling the animal into thinking food was nearby.

24 Sep 2012

Device / Technology News

U.S. District Court rules in favor of Alnylam in patent infringement case against Tekmira

New technique can identify cell-secreted proteins

New computer program predicts most stable structures of nanometer-sized collagen

NeuroSigma to launch Monarch eTNS system at 10th European Congress on Epileptology

Positive results from Antares Pharma’s VIBEX MTX clinical study on rheumatoid arthritis

Pervenio Lung RS from Life Technologies

LIFR protein suppresses local invasion and metastasis of breast cancer cells

NVIDIA video cards can help reduce radiation exposure from X-ray and CT scans

X2IMPACT, NFL enter agreement to supply Concussion Management System software app

Lack of cytokeratin 6A may lead to eye infections

Toshiba announces expansion of Assurance Program to offer ultrasound systems

Endorectal MRI helps assess eligibility of men with prostate cancer for active surveillance

Amcom Software launches clinical alerting middleware at St. Vincent's Melbourne

Celleration introduces new MIST 360 Applicator

New nanotechnology detects micrometastases in mouse models of breast cancer

PAM50 potentially simplifies underlying breast tumor biology

Combination of healing touch and guided imagery reduces depression, cynicism among US Marines

Study tracks and compares brain growth in chimpanzee and human fetuses

Siemens perioperative management solution by SIS for Wentworth-Douglass Hospital

Lasers manipulate neurons in worms' brains

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News